Synlett 2006(17): 2777-2780  
DOI: 10.1055/s-2006-950254
LETTER
© Georg Thieme Verlag Stuttgart · New York

Design and Synthesis of Angucyclinone 5-Aza Analogues

Jaime A. Valderrama*, M. Florencia González, Pamela Colonelli, David Vásquez
Facultad de Química, Pontificia Universidad Católica de Chile, Casilla 306, Santiago, Chile
Fax: +56(2)6864744; e-Mail: jvalderr@uc.cl;
Weitere Informationen

Publikationsverlauf

Received 3 July 2006
Publikationsdatum:
09. Oktober 2006 (online)

Abstract

A highly efficient one-pot procedure for the synthesis of phenanthridine-1,7,10-triones from acylbenzoquinones and cyclic enaminones is reported. The cycloaddition reactions of these quinones with 1-trimethylsilyloxybutadiene followed by hydrolysis and oxidative processes provide entry to a variety of angucyclinone 5-aza analogues.

    References and Notes

  • 1a Krapcho AP. Petry ME. Getahun Z. Landi JJ. Stallman J. Polsenberg JF. Gallagher CE. Maresch MJ. Hacker MP. J. Med. Chem.  1994,  37:  828 
  • 1b Krapcho AP. Menta E. Oliva A. Di Domenico R. Fiocchi L. Maresch ME. Gallagher CE. Hacker MP. Beggiolin G. Giuliani FC. Pezzoni G. Spinelli S. J. Med. Chem.  1998,  41:  5429 
  • 2 Kita Y. Kirihara M. Fujii Y. Okunaka R. Akai S. Maeda H. Tamura Y. Shimooka K. Ohishi H. Ishida T. Chem. Pharm. Bull.  1991,  39:  857 
  • 3 Lee H. Lee S.-I. Yang S.-I. Bioorg. Med. Chem. Lett.  1998,  8:  2991 
  • 4 Tudor G. Gutierrez P. Aguilera-Gutierrez A. Sausville EA. Biochem. Pharmacol.  2003,  65:  1061 
  • 5 Rohr J. Thiericke R. Nat. Prod. Rep.  1992,  9:  103 
  • 6 Krohn K. Rohr J. Top. Curr. Chem.  1997,  188:  127 
  • 7 Collet SC. Rémi J.-F. Cariou C. Laib S. Guingant AY. Vu NQ. Dujardin G. Tetrahedron Lett.  2004,  45:  4911 
  • 8a Valderrama JA. González MF. Pessoa-Mahana D. Tapia RA. Fillion H. Pautet F. Rodríguez JA. Theoduloz C. Schmeda-Hishmann G. Bioorg. Med. Chem.  2006,  14:  5003 
  • 8b Valderrama JA. Espinoza O. González MF. Tapia RA. Rodríguez JA. Theoduloz C. Schmeda-Hishmann G. Tetrahedron  2006,  62:  2631 
  • 8c Valderrama JA. Benites J. Cortés M. Pessoa-Mahana H. Prina E. Fournet A. Bioorg. Med. Chem.  2003,  11:  4713 
  • 8d Tapia RA. Alegría L. Pessoa CD. Salas C. Cortés MJ. Valderrama JA. Sarciron M.-E. Pautet F. Walchshofer N. Fillon H. Bioorg. Med. Chem.  2003,  11:  2175 
  • 8e Valderrama JA. Benites J. Cortés M. Pessoa-Mahana D. Prina E. Fournet A. Tetrahedron  2002,  58:  881 
  • 8f Valderrama JA. Astudillo C. Tapia RA. Prina E. Estrabaud E. Mahieux R. Fournet A. Chem. Pharm. Bull.  2002,  50:  1215 
  • 8g Valderrama JA. Pessoa-Mahana D. Tapia R. Rojas de Arias A. Nakayama H. Torres S. Miret J. Ferreira ME. Tetrahedron  2001,  57:  8653 
  • 9 Ruiz VM. Tapia R. Valderrama JA. Vega JC. J. Heterocycl. Chem.  1981,  18:  1161 
  • 10 Cassis R. Valderrama JA. Synth. Commun.  1983,  13:  347 
  • 12a Flemming I. Frontier Orbitals and Organic Chemical Reactions   Wiley; New York: 1976. 
  • 12b Rozeboom MD. Tegmo-Larsson I.-M. Houk KN. J. Org. Chem.  1981,  46:  2338 
  • 13 The LUMO eigenvector coefficients were determined using the semiempirical PM3 method implemented in the Spartan package: Spartan version 5.1.3   Wavefunction Inc.; Irvine CA: 1999. 
  • 14 Valderrama JA. Araya-Maturana R. González F. Tapia R. Fariña F. Paredes MC. J. Chem. Soc., Perkin Trans. 1  1991,  555 
  • 15 Krohn K. Tetrahedron Lett.  1980,  21:  3557 
11

Synthesis of 3,3,6-Trimethyl-2 H -3,4-dihydro­phen­-anthridine-1,7,10-trione (5d); Typical Procedure. A suspension of 2,5-dihydroxyacetophenone (1b; 152 mg, 1.0 mmol), 3-amino-5,5-dimethyl-2-cyclohexen-1-one (2b; 139 mg, 1.0 mmol), silver(I) oxide (464 mg, 2.0 mmol), MgSO4 (420 mg) and CH2Cl2 (20 mL) was vigorously stirred for 2 h at r.t. The mixture was filtered and the filtrate was evaporated under vacuum to give crude quinone 5d (214 mg, 0.8 mmol, 80%). Further column chromatography of the crude product (silica; CH2Cl2-EtOAc, 9:1) yielded pure 5d (175 mg, 0.65 mmol, 65%) as a yellow solid; mp 131-132 °C; R f 0.49 (silica; CH2Cl2-EtOAc, 9:1). IR (KBr): 2969 (w), 1694 (s), 1668 (vs), 1610 (w), 1556 (s), 1469 (w), 1437 (w), 1391 (m), 1373 (m), 1359 (w), 1338 (s), 1311 (m), 1258 (s), 1225 (s), 1182 (w), 1155 (w), 1110 (m), 1052 (m) cm-1. 1H NMR (400 MHz, CDCl3): δ = 1.15 (s, 6 H), 2.75 (s, 2 H), 2.97 (s, 3 H), 3.06 (s, 2 H), 6.86 (d, J = 10.3 Hz, 1 H), 7.05 (d, J = 10.3 Hz, 1 H). 13C NMR (100 MHz, CDCl3): δ = 26.22 (CH3), 28.73 (2 × CH3), 33.51 (C), 47.47 (CH2), 53.28 (CH2), 123.57 (C), 126.08 (C), 138.09 (CH), 138.48 (CH), 141.57 (C), 163.53 (C), 165.66 (C), 184.78 (C), 184.91 (C), 196.96 (C). Anal. Calcd for C16H15NO3: C, 71.36; H, 5.61; N, 5.20. Found: C, 71.22; H, 5.50; N, 5.19.

16

Synthesis of Benzo[ j ]phenanthridine-1,7,12-trione 7h; Typical Procedure for Method B: A solution of 6d (105 mg, 0.25 mmol), HCl acid (3 drops, 5%) in aq THF (6 mL, 90%) was left at r.t. for 1 h. The mixture was diluted with H2O (10 mL) and then extracted with CHCl3 (2 × 15 mL). The organic layer was washed with H2O (2 × 10 mL), dried over MgSO4, and evaporated under vacuum. The residue was dissolved in CH2Cl2 (10 mL) and the solution was added to a stirred solution of pyridinium chlorochromate (412 mg, 1.91 mmol), NaOAc (95 mg, 1.16 mmol) in CH2Cl2 (10 mL), and the mixture was stirred for 1.5 h at r.t. The resulting mixture was chromatographed (silica; CH2Cl2-EtOAc, 9:1) to give pure 7h (65.4 mg, 0.195 mmol, 78%) as an orange solid; mp 166-167 °C (dec.); R f 0.14 (silica; CH2Cl2-EtOAc, 9:1). IR (KBr): 3449 (w), 1708 (s), 1678 (s), 1636 (vs), 1571 (s), 1447 (s), 1367 (m), 1333 (s), 1283 (s), 1270 (s), 1243 (m) cm-1. 1H NMR (400 MHz, CDCl3): δ = 1.15 (s, 6 H), 2.77 (s, 2 H), 3.07 (s, 5 H), 7.28 (m, 1 H), 7.60 (m, 2 H), 12.30 (s, 1 H). 13C NMR (100 MHz, CDCl3): δ = 27.33 (CH3), 28.80 (2 × CH3), 47.5 (CH2), 53.3 (CH2), 116.1 (C), 119.0 (CH), 124.5 (CH), 125.0 (C), 127.0 (C), 134.3 (C), 136.8 (CH), 144.4 (C), 162.0 (C), 164.5 (C), 166.0 (C), 183.6 (C), 189.0 (C), 197.0 (C). Anal. Calcd for C20H17NO4: C, 71.63; H, 5.11; N, 4.18. Found: C, 71.45; H, 4.94; N, 4.21.